Simone Scuderi

Feb 9, 2023 | europeanurology.com | Francesco Montorsi |Simone Scuderi |Alberto Briganti |Giorgio Gandaglia

We read with interest the Platinum Opinion by Schilham et al. [] on how advanced imaging modalities might solve the current diagnostic challenges for patients with prostate cancer (PCa). Although we agree with the authors that new imaging techniques will overcome the limitations of conventional approaches and will play a major role soon, some points warrant further attention.

Feb 9, 2023 | europeanurology.com | Francesco Montorsi |Simone Scuderi |Alberto Briganti |Giorgio Gandaglia

We read with interest the editorial by Powell et al. [] questioning the recent approval by the US Food and Drug Administration and the European Medicines Agency of the first oral gonadotropin-releasing hormone (GnRH) antagonist relugolix for the treatment of patients with advanced prostate cancer (PCa) [].